Direct HDL Cholesterol (HDL)
Ldl & Vldl Precipitation, Cholesterol Via Esterase-Oxidase, Hdl. 510(k) K153435, from Randox Laboratories, Ltd. (Crumlin, GB). Product code LBS, class 1.
As of Nov 20, 2026, K153435 is an FDA 510(k) held by Randox Laboratories, Ltd., substantially equivalent on Jan 8, 2016 after 42 days, with no recalls tied to it in FDA's recall database.
- Review time: 42 days
- Recalls: 0
For the quantitative in vitro determination of HDL Cholesterol in serum and plasma. Such measurements are used in the diagnosis and treatment of lipid disorders (such as diabetes mellitus), atherosclerosis and various other liver and renal diseases and for the assessment for the risk of developing cardiovascular disease. This in vitro diagnostic device is intended for Rx Only.
- Direct Hdl-Cholestrol LiquidK982341 · Randox Laboratories, Ltd. · Jul 30, 1998
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 27, 2015
- Review panel
- Clinical Chemistry
- Regulation
- 21 CFR 862.1475
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files